No risk of maternal EBV infection for childhood leukemia

Rosamaria Tedeschi, Tapio Luostarinen, Alessia Marus, Davit Bzhalava, Helga M. Ögmundsdottir, Joakim Dillner, Paolo De Paoli, Heljä Marja Surcel, Eero Pukkala, Matti Lehtinen, Tuula Lehtinen

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

We performed a large nested case-control study within the Finnish and Icelandic maternity cohorts to verify/ falsify the association of maternal EBV infection with an increased risk of acute lymphoblastic leukemia (ALL) in the offspring found in previous studies. All hematologic malignancies diagnosed among children born during 1983 to 2006 in Finland and 1997 to 2005 in Iceland were identified through national cancer registries. For each index mother of a leukemia case, three matched control mothers with cancer-free offspring were identified. First trimester sera from 561 ALL and 144 non-ALL index mothers and from 2,105 control mothers were analyzed for antibodies to EBV viral capsid antigen (IgG and IgM), early antigen (IgG) and ZEBRA protein (IgG). Conditional logistic regression-based estimates of odds ratios and 95% confidence intervals adjusted for birth order and sib-ship size were calculated. Overall, there was no evidence of increased risk of ALL associated to EBV viral capsid antigen IgM (odds ratio, 0.9; 95% confidence interval, 0.5-1.8). The early antigen and ZEBRA antibodies (EBV reactivation markers) were also not associated with risk. The data argue against a role of EBV in ALL.

Original languageEnglish
Pages (from-to)2790-2792
Number of pages3
JournalCancer Epidemiology Biomarkers and Prevention
Volume18
Issue number10
DOIs
Publication statusPublished - Oct 2009

Fingerprint

Epstein-Barr Virus Infections
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Leukemia
Mothers
Viral Antigens
Immunoglobulin G
Human Herpesvirus 4
Immunoglobulin M
Odds Ratio
Confidence Intervals
Iceland
Antigens
Birth Order
Ships
Antibodies
Hematologic Neoplasms
First Pregnancy Trimester
Finland
Registries
Case-Control Studies

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Tedeschi, R., Luostarinen, T., Marus, A., Bzhalava, D., Ögmundsdottir, H. M., Dillner, J., ... Lehtinen, T. (2009). No risk of maternal EBV infection for childhood leukemia. Cancer Epidemiology Biomarkers and Prevention, 18(10), 2790-2792. https://doi.org/10.1158/1055-9965.EPI-09-0751

No risk of maternal EBV infection for childhood leukemia. / Tedeschi, Rosamaria; Luostarinen, Tapio; Marus, Alessia; Bzhalava, Davit; Ögmundsdottir, Helga M.; Dillner, Joakim; De Paoli, Paolo; Surcel, Heljä Marja; Pukkala, Eero; Lehtinen, Matti; Lehtinen, Tuula.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 18, No. 10, 10.2009, p. 2790-2792.

Research output: Contribution to journalArticle

Tedeschi, R, Luostarinen, T, Marus, A, Bzhalava, D, Ögmundsdottir, HM, Dillner, J, De Paoli, P, Surcel, HM, Pukkala, E, Lehtinen, M & Lehtinen, T 2009, 'No risk of maternal EBV infection for childhood leukemia', Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 10, pp. 2790-2792. https://doi.org/10.1158/1055-9965.EPI-09-0751
Tedeschi R, Luostarinen T, Marus A, Bzhalava D, Ögmundsdottir HM, Dillner J et al. No risk of maternal EBV infection for childhood leukemia. Cancer Epidemiology Biomarkers and Prevention. 2009 Oct;18(10):2790-2792. https://doi.org/10.1158/1055-9965.EPI-09-0751
Tedeschi, Rosamaria ; Luostarinen, Tapio ; Marus, Alessia ; Bzhalava, Davit ; Ögmundsdottir, Helga M. ; Dillner, Joakim ; De Paoli, Paolo ; Surcel, Heljä Marja ; Pukkala, Eero ; Lehtinen, Matti ; Lehtinen, Tuula. / No risk of maternal EBV infection for childhood leukemia. In: Cancer Epidemiology Biomarkers and Prevention. 2009 ; Vol. 18, No. 10. pp. 2790-2792.
@article{b11a7794ec4744dbb6875ca34a7372d9,
title = "No risk of maternal EBV infection for childhood leukemia",
abstract = "We performed a large nested case-control study within the Finnish and Icelandic maternity cohorts to verify/ falsify the association of maternal EBV infection with an increased risk of acute lymphoblastic leukemia (ALL) in the offspring found in previous studies. All hematologic malignancies diagnosed among children born during 1983 to 2006 in Finland and 1997 to 2005 in Iceland were identified through national cancer registries. For each index mother of a leukemia case, three matched control mothers with cancer-free offspring were identified. First trimester sera from 561 ALL and 144 non-ALL index mothers and from 2,105 control mothers were analyzed for antibodies to EBV viral capsid antigen (IgG and IgM), early antigen (IgG) and ZEBRA protein (IgG). Conditional logistic regression-based estimates of odds ratios and 95{\%} confidence intervals adjusted for birth order and sib-ship size were calculated. Overall, there was no evidence of increased risk of ALL associated to EBV viral capsid antigen IgM (odds ratio, 0.9; 95{\%} confidence interval, 0.5-1.8). The early antigen and ZEBRA antibodies (EBV reactivation markers) were also not associated with risk. The data argue against a role of EBV in ALL.",
author = "Rosamaria Tedeschi and Tapio Luostarinen and Alessia Marus and Davit Bzhalava and {\"O}gmundsdottir, {Helga M.} and Joakim Dillner and {De Paoli}, Paolo and Surcel, {Helj{\"a} Marja} and Eero Pukkala and Matti Lehtinen and Tuula Lehtinen",
year = "2009",
month = "10",
doi = "10.1158/1055-9965.EPI-09-0751",
language = "English",
volume = "18",
pages = "2790--2792",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "10",

}

TY - JOUR

T1 - No risk of maternal EBV infection for childhood leukemia

AU - Tedeschi, Rosamaria

AU - Luostarinen, Tapio

AU - Marus, Alessia

AU - Bzhalava, Davit

AU - Ögmundsdottir, Helga M.

AU - Dillner, Joakim

AU - De Paoli, Paolo

AU - Surcel, Heljä Marja

AU - Pukkala, Eero

AU - Lehtinen, Matti

AU - Lehtinen, Tuula

PY - 2009/10

Y1 - 2009/10

N2 - We performed a large nested case-control study within the Finnish and Icelandic maternity cohorts to verify/ falsify the association of maternal EBV infection with an increased risk of acute lymphoblastic leukemia (ALL) in the offspring found in previous studies. All hematologic malignancies diagnosed among children born during 1983 to 2006 in Finland and 1997 to 2005 in Iceland were identified through national cancer registries. For each index mother of a leukemia case, three matched control mothers with cancer-free offspring were identified. First trimester sera from 561 ALL and 144 non-ALL index mothers and from 2,105 control mothers were analyzed for antibodies to EBV viral capsid antigen (IgG and IgM), early antigen (IgG) and ZEBRA protein (IgG). Conditional logistic regression-based estimates of odds ratios and 95% confidence intervals adjusted for birth order and sib-ship size were calculated. Overall, there was no evidence of increased risk of ALL associated to EBV viral capsid antigen IgM (odds ratio, 0.9; 95% confidence interval, 0.5-1.8). The early antigen and ZEBRA antibodies (EBV reactivation markers) were also not associated with risk. The data argue against a role of EBV in ALL.

AB - We performed a large nested case-control study within the Finnish and Icelandic maternity cohorts to verify/ falsify the association of maternal EBV infection with an increased risk of acute lymphoblastic leukemia (ALL) in the offspring found in previous studies. All hematologic malignancies diagnosed among children born during 1983 to 2006 in Finland and 1997 to 2005 in Iceland were identified through national cancer registries. For each index mother of a leukemia case, three matched control mothers with cancer-free offspring were identified. First trimester sera from 561 ALL and 144 non-ALL index mothers and from 2,105 control mothers were analyzed for antibodies to EBV viral capsid antigen (IgG and IgM), early antigen (IgG) and ZEBRA protein (IgG). Conditional logistic regression-based estimates of odds ratios and 95% confidence intervals adjusted for birth order and sib-ship size were calculated. Overall, there was no evidence of increased risk of ALL associated to EBV viral capsid antigen IgM (odds ratio, 0.9; 95% confidence interval, 0.5-1.8). The early antigen and ZEBRA antibodies (EBV reactivation markers) were also not associated with risk. The data argue against a role of EBV in ALL.

UR - http://www.scopus.com/inward/record.url?scp=70350103717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350103717&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-09-0751

DO - 10.1158/1055-9965.EPI-09-0751

M3 - Article

C2 - 19755652

AN - SCOPUS:70350103717

VL - 18

SP - 2790

EP - 2792

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 10

ER -